Pacific Biosciences of California, Inc. (PACB) Gross margin 2016–2025
Pacific Biosciences of California, Inc. (PACB) gross margin by fiscal year — reported gross profit divided by reported revenue.
28.6%FY2025 · since FY2016: 48.7% → 28.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 28.6% | +4.4 pp |
| FY2024 | 24.2% | -2.1 pp |
| FY2023 | 26.3% | -11.9 pp |
| FY2022 | 38.2% | -6.9 pp |
| FY2021 | 45.1% | +3.8 pp |
| FY2020 | 41.3% | +3.2 pp |
| FY2019 | 38.0% | +6.1 pp |
| FY2018 | 31.9% | -5.2 pp |
| FY2017 | 37.1% | -11.6 pp |
| FY2016 | 48.7% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice